Breaking News Instant updates and real-time market news.

BA

Boeing

$347.91

-9.02 (-2.53%)

14:46
11/13/18
11/13
14:46
11/13/18
14:46

Pilots claim Boeing Lion Air crash linked to improper training, FT reports

Pilot associations said that Boeing did not properly warn pilots in their training about a possible risk associated with the flight control system on its 737 Max aircraft that has been connected to the crash of a Lion Air jet in Indonesia a month ago, the Financial Times reports. U.S. pilot organizations said that the U.S. company failed to provide proper information that the automated stall prevention system on the new jet could, under certain circumstances, try to force down the nose of the aircraft hard even if pilots are flying it manually, the report notes. "In the pilot world, information is key to survival," Dennis Tajer, a 737 captain and spokesman for the Allied Pilots Association at American Airlines Group, told the Financial Times. "Information was not provided to us in our training or our manuals regarding this difference in the systems." Reference Link

BA Boeing
$347.91

-9.02 (-2.53%)

10/25/18
JEFF
10/25/18
NO CHANGE
Target $420
JEFF
Buy
Boeing price target raised to $420 from $415 at Jefferies
In a post-earnings research note titled "When The Boeing is Good....," Jefferies analyst Sheila Kahyaoglu raised her price target for Boeing shares to $420 from $415. The analyst says the company's Q3 results highlighted many of the trends that support her Buy investment thesis, including productivity-driven earnings growth and cap deployment optionality.
10/25/18
ADAM
10/25/18
NO CHANGE
Target $360
ADAM
Hold
Boeing price target raised to $360 from $350 at Canaccord
Canaccord analyst Ken Herbert raised his price target for Boeing to $360 from $350 following the company's quarterly results. In a research note to investors, Herbert says that while the results were better than expected and the stock significantly outperformed the broader market, he is maintaining a Hold rating. He continues to see pressure to the long-term margin rates, investment sentiment around the NMA, macro risk and new program development in both the commercial and defense markets, but acknowledges that free cash flow remains strong and Boeing has basically won what he views as the "must-win" BDS competitions.
10/26/18
BERN
10/26/18
NO CHANGE
Target $440
BERN
Outperform
Boeing price target raised to $440 from $426 at Bernstein
Bernstein analyst Douglas Harnad raised his price target on Boeing to $440 from $426 following the company's "strong" Q3 results, telling investors in a research note that the main driver of Q3 was Boeing Commercial Airplanes performance, with margins above his estimates. Harnad does not expect the company's deals on the T-X trainer and the MQ-25 aircraft to derail an otherwise positive story at Boeing, as stock performance is dominated by BCA. Harnad has an Outperform rating on shares.
11/13/18
JEFF
11/13/18
NO CHANGE
Target $420
JEFF
Buy
Boeing deliveries start quarter slow as expected, says Jefferies
In October, Boeing delivered 57 commercial aircraft versus 56 a year ago and the 87 delivered in September 2018, Jefferies analyst Sheila Kahyaoglu tells investors in a research note titled "October Deliveries: Slow Start to the Q as Expected." She notes that October deliveries were 24% of her total Q4 forecast versus the 27% of Q4 deliveries in October of last year. Boeing's deliveries are expected to ramp in November and December as is the typical seasonal pattern, writes Kahyaoglu. She continues to forecast 242 deliveries for Q4 and 810 for the full year. The analyst keeps a Buy rating on Boeing with a $420 price target.

TODAY'S FREE FLY STORIES

NVS

Novartis

$75.84

0.42 (0.56%)

05:38
04/24/19
04/24
05:38
04/24/19
05:38
Earnings
Novartis raises FY19 core operating income view to high single-digit growth »

Expects FY19 revenue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 04

    May

  • 08

    May

  • 22

    May

  • 31

    May

NVS

Novartis

$75.84

0.42 (0.56%)

05:36
04/24/19
04/24
05:36
04/24/19
05:36
Earnings
Novartis reports Q1 core EPS $1.21, consensus $1.20 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 04

    May

  • 08

    May

  • 22

    May

  • 31

    May

VBIV

VBI Vaccines

$2.00

0.05 (2.56%)

05:34
04/24/19
04/24
05:34
04/24/19
05:34
Conference/Events
VBI Vaccines to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 23

    May

PLCE

Children's Place

$109.92

2.95 (2.76%)

05:34
04/24/19
04/24
05:34
04/24/19
05:34
Initiation
Children's Place initiated  »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAC

TransAlta

$6.88

-0.175 (-2.48%)

05:32
04/24/19
04/24
05:32
04/24/19
05:32
Hot Stocks
TransAlta comments on Mangrove Partners release, urges holders to vote BLUE card »

TransAlta commented on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

CRI

Carter's

$105.13

2.02 (1.96%)

05:31
04/24/19
04/24
05:31
04/24/19
05:31
Initiation
Carter's initiated  »

Carter's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 16

    May

STRL

Sterling Construction

$13.77

0.19 (1.40%)

05:30
04/24/19
04/24
05:30
04/24/19
05:30
Hot Stocks
Sterling Construction awarded $23M contract by UDOT »

Sterling Construction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 08

    May

COST

Costco

$245.56

2.1 (0.86%)

05:27
04/24/19
04/24
05:27
04/24/19
05:27
Recommendations
Costco analyst commentary at Baird »

Costco price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 30

    May

EBAY

eBay

$36.66

0.51 (1.41%)

05:22
04/24/19
04/24
05:22
04/24/19
05:22
Recommendations
eBay analyst commentary  »

eBay price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$262.32

1.39 (0.53%)

05:19
04/24/19
04/24
05:19
04/24/19
05:19
Recommendations
Abiomed analyst commentary at Piper Jaffray »

CMS proposed rate changes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 05

    Jun

  • 13

    Nov

MMSI

Merit Medical

$59.13

1.57 (2.73%)

05:16
04/24/19
04/24
05:16
04/24/19
05:16
Recommendations
Merit Medical analyst commentary at Piper Jaffray »

Piper calls Merit Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 08

    May

  • 23

    May

HOLX

Hologic

$44.26

1.26 (2.93%)

05:13
04/24/19
04/24
05:13
04/24/19
05:13
Recommendations
Hologic analyst commentary at Piper Jaffray »

Hologic checks suggest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 03

    May

  • 07

    May

  • 29

    May

  • 05

    Jun

SYK

Stryker

$186.95

4.905 (2.69%)

05:09
04/24/19
04/24
05:09
04/24/19
05:09
Recommendations
Stryker analyst commentary at Piper Jaffray »

Stryker's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 08

    May

  • 29

    May

ICLK

iClick Interactive Asia

$3.89

-0.115 (-2.87%)

05:08
04/24/19
04/24
05:08
04/24/19
05:08
Hot Stocks
iClick enters marketing technology joint venture with VGI »

VGI Global Media and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$36.66

0.51 (1.41%)

05:05
04/24/19
04/24
05:05
04/24/19
05:05
Recommendations
eBay analyst commentary  »

eBay price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$38.92

-0.79 (-1.99%)

05:03
04/24/19
04/24
05:03
04/24/19
05:03
Downgrade
Harley-Davidson rating change  »

Harley-Davidson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

BBY

Best Buy

$73.60

1 (1.38%)

05:02
04/24/19
04/24
05:02
04/24/19
05:02
Upgrade
Best Buy rating change at Jefferies »

Best Buy upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

FOJCY

Fortum

$0.00

(0.00%)

05:00
04/24/19
04/24
05:00
04/24/19
05:00
Upgrade
Fortum rating change  »

Fortum upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGLOY

Anglo American

$0.00

(0.00%)

04:58
04/24/19
04/24
04:58
04/24/19
04:58
Downgrade
Anglo American rating change  »

Anglo American downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$11.99

0.46 (3.99%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Upgrade
Snap rating change at JPMorgan »

Snap upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PIRS

Pieris Pharmaceuticals

$2.93

0.01 (0.34%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
Pieris Pharmaceuticals management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

MPSYF

Morphosys AG

$0.00

(0.00%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
Morphosys AG management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

MOR

MorphoSys

$24.78

0.7 (2.91%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
MorphoSys management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 08

    May

  • 20

    Jun

NTGN

Neon Therapeutics

$6.21

0.03 (0.49%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
Neon Therapeutics management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

AXU

Alexco Resource

$0.96

-0.0396 (-3.98%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
Alexco Resource management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 01

    May

  • 02

    May

  • 03

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.